GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15

• RNAseq OVCAR3 following GPX3 knock-down (Figure 2): https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254035

Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian Cancer

• RNAseq OVCAR4 following MPZL3 knock-down (Figure 2A): https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296257
• RNAseq OVCA433 following MPZL3 knock-down (Figure 2B): https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296256